Kukje Pharma Co Ltd
KRX:002720
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/E
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.
Valuation Scenarios
If P/E returns to its 3-Year Average (16.8), the stock would be worth ₩4 515 (6% downside from current price).
| Scenario | P/E Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 17.8 | ₩4 780 |
0%
|
| 3-Year Average | 16.8 | ₩4 515 |
-6%
|
| 5-Year Average | 15 | ₩4 030.11 |
-16%
|
| Industry Average | 14.9 | ₩4 015.27 |
-16%
|
| Country Average | 13.9 | ₩3 734.99 |
-22%
|
Forward P/E
Today’s price vs future net income
Peer Comparison
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| KR |
|
Kukje Pharma Co Ltd
KRX:002720
|
101.1B KRW | 17.8 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
804.2B USD | 39 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
547.4B USD | 26 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212.4B GBP | 27.5 | |
| CH |
|
Novartis AG
SIX:NOVN
|
220.1B CHF | 19.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
274.6B USD | 15 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 11.1 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
149.3B USD | 19.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.9B USD | 16.4 |
Market Distribution
| Min | 0.2 |
| 30th Percentile | 8.5 |
| Median | 13.9 |
| 70th Percentile | 23.4 |
| Max | 7 223 |
Other Multiples
Kukje Pharma Co Ltd
Glance View
KUKJE PHARMA Co. Ltd. engages in the manufacture, sale, and distribution of pharmaceutical, cosmetics, and healthcare products. The company is headquartered in Seongnam, Gyeonggi-Do. Co., Ltd, is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products are finished products, such as antibiotics, other antibiotics for injection, antifungal and antiviral agents, agents for gastrointestinal tract and liver, muscle relaxants, anti-osteoporotics, corticosteroids, agents for cardiovascular and endocrine systems, ophthalmic agents, remedies for central nervous system (CNS) disorders, remedies for urinary systems, antihistamines, antitussives, cough and cold remedies, non-steroidal anti inflammatory drugs (NSAIDs), antitussive, cough and cold remedies, as well as other over-the-counter (OTC) drugs. The company also provides raw materials, such as ceftriaxone sodium sterile, cefuroxime axetil, ceftezole sodium sterile, cefminox sodium sterile, cefuroxime sodium sterile and others.
